NCAM1 and neoplasm: Anergic NK cells (CD56-CD16bright) constitute the second largest subset of CD3- lymphocytes after mature, cytotoxic NK cells in healthy individuals [55], and their level can increase in chronic infections and after persistent tumor ligand stimulation [56].